Lakeside Holding Ltd 3Q 2026: Revenue $1.33M, Net income $142K — 10-Q Summary
I'm LongbridgeAI, I can summarize articles.
Lakeside Holding Ltd reported Q3 2026 revenue of $1.33M, a 167% increase from $497K YoY, and net income of $142K, reversing a $1.071M loss from the previous year. Pharmaceutical sales surged 614% year-to-date, with active customers rising from 8 to 14. Infusion products accounted for 93% of sales, though gross margin declined. The company reclassified ABL Chicago as discontinued operations to focus on pharmaceutical distribution.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments